Variant genotypes of MDR1 C3435T increase the risk of leukemia: Evidence from 10 casecontrol studies

Leukemia and Lymphoma

Volumn 53, Issue 6, 2012, Pages 1183-1187

  Qian, Xifeng ^a   Cao, Songyu ^b   Yang, Guohua ^a   Dong, Jing ^b   Jin, Guangfu ^b   Shen, Yunfeng ^a   Hu, Zhibin ^b  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

C3435T; Leukemia; MDR1; Polymorphism

Indexed keywords

MULTIDRUG RESISTANCE PROTEIN 1;

ACUTE LEUKEMIA; ALLELE; ARTICLE; CANCER RISK; CHRONIC LYMPHATIC LEUKEMIA; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; PRIORITY JOURNAL; PUBLISHING;

ADULT; CASE-CONTROL STUDIES; CHILD; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEUKEMIA; P-GLYCOPROTEIN; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84861381150     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.641179     Document Type: Article

References (48)

1. Ambudkar SV, Dey S, Hrycyna CA, et al. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Anne Rev Pharmacol Toxicol 1999;39:361-398. (Pubitemid 29222564)
2. Sakaeda T. MDR1 genotype-related pharmacokinetics: fact or fi ction? Drug Metab Pharmacokinet 2005;20:391-414.
3. Hur EH, Lee JH, Lee MJ, et al. C3435T polymorphism of the MDR1 gene is not associated with P-glycoprotein function of leukemic blasts and clinical outcome in patients with acute myeloid leukemia. Leuk Res 2008;32:1601-1604.
4. Henriquez-Hernandez LA, Murias-Rosales A, Gonzalez- Hernandez A, et al. Distribution of TYMS, MTHFR, p53 and MDR1 gene polymorphisms in patients with breast cancer treated with neoadjuvant chemotherapy. Cancer Epidemiol 2010;34:634-638.
5. Hoff meyer S, Burk O, Richter OV, et al. Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo. Proc Natl Acad Sci USA 2000;97:3473-3478. (Pubitemid 30183327)
6. Zubor P, Lasabova Z, Hatok J, et al. A polymorphism C3435T of the MDR-1 gene associated with smoking or high body mass index increases the risk of sporadic breast cancer in women. Oncol Rep 2007;18:211-217.
7. Cizmarikova M, Wagnerova M, Schonova L, et al. MDR1 (C3435T) polymorphism: relation to the risk of breast cancer and therapeutic outcome. Pharmacogenomics J 2010;10:62-69.
8. Henriquez-Hernandez LA, Rosales AM, Gonzalez AH, et al. Gene polymorphisms in TYMS, MTHFR, p53 and MDR1 as risk factors for breast cancer: a case-control study. Oncol Rep 2009;22:1425-1433.
9. Turgut S, Yaren A, Kursunluoglu R, et al. MDR1 C3435T polymorphism in patients with breast cancer. Arch Med Res 2007;38:539-544. (Pubitemid 46873813)
10. Khedri A, Nejat-Shokouhi A, Salek R, et al. Association of the colorectal cancer and MDR1 gene polymorphism in an Iranian population. Mol Biol Rep 2011;38:2939-2943.
11. Osswald E, Johne A, Laschinski G, et al. Association of MDR1 genotypes with susceptibility to colorectal cancer in older nonsmokers. Eur J Clin Phamacol 2007;63:9-16. (Pubitemid 46025468)
12. Kurzwski M, Drozdzik M, Suchy J, et al. Polymorphism in the P-glycoprotein drug transporter gene in colon cancer patients. Eur J Clin Pharmacol 2005;61:389-394. (Pubitemid 41569314)
13. Chang H, Rha SY, Jeung HC, et al. Association of the ABCB1 3435C+T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy. Oncol Rep 2010;23:271-278. Tahara
14. T, Arisawa T, Shibata T, et al. Multi-drug resistance 1 polymorphism is associated with reduced risk of gastric cancer in the Japanese population. J Gastroenterol Hepatol 2007;22:1678-1682. (Pubitemid 47383331)
15. Sabahi Z, Salek R, Heravi RE, et al. Association of gastric cancer incidence with MDR1 gene polymorphism in an ethnic Iranian population. Indian J Cancer 2010;47:317-321.
16. Chen HC, Hu WX, Liu QX, et al. Genetic polymorphisms of metabolic enzymes CYP1A1, CYP2D6, GSTM1 and GSTT1 and leukemia susceptibility. Eur J Cancer Prev 2008;17:251-258.
17. Rao DN, Anuradha C, Vishnupriya S, et al. Association of an MDR1 gene polymorphism with acute leukemia in India. Asian Pacifi c J Cancer Prev 2010;11:1063-1066.
18. Semsei AF, Erdelyi DJ, Ungvari I, et al. Association of some rare haplotypes and genotype combinations in the MDR1 gene with childhood acute lymphoblastic leukaemia. Leuk Res 2008;32: 1214-1220.
19. Hattori H, Suminoe A, Wada M, et al. Regulatory polymorphism of multidrug resistance 1 (MDR1) gene are associated with the development of childhood acute lymphoblastic leukemia. Leuk Res 2007;31:1633-1640. (Pubitemid 350051403)
20. U rayama KY, Wiencke JK, Buffl er PA, et al. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. Cancer Epidemiol Biomarkers Prev 2007;16:1172-1177. (Pubitemid 46984955)
21. J amroziak K, Balcerczak E, Cebula B, et al. No infl uence of 3435C+T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cells. Ther Drug Monit 2006;28:707-711. (Pubitemid 44564075)
22. J amroziak K, Mlynarski W, Balcerczak E, et al. Functional C3435T polymorphism of MDR1 gene: an impact on genetic susceptibility and clinical outcome of childhood acute lymphoblastic leukemia. Eur J Haematol 2004;72:314-321. (Pubitemid 38520728)
23. L eal-Ugarte E, Gutierrez-Angulo M, Macias-Gomez NM, et al. MDR1 C3435T polymorphism in Mexican children with acute lymphoblastic leukemia and in healthy individuals. Hum Biol 2008;80:449-455.
24. Penna G, Allegra A, Alonci A, et al. MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia:an impact on susceptibility and prognosis. Med Oncol 2011;28:1549-1554.
25. Jamroziak K, Balcerczak E, Smolewski P, et al. MDR1 (ABCB1) gene polymorphism C3435T is associated with P-glycoprotein activity in B-cell chronic lymphocytic leukemia. Pharmacol Rep 2006;58: 720-728. (Pubitemid 44741691)
26. Green H, Falk IJ, Lotfi K, et al. Association of ABCB1 polymorphisms with survival and in vitro cytotoxicty in de novo acute myeloid leukemia with normal karyotype. Pharmacogenomics J 2010 Oct 12. [Epub ahead of print]
27. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820-826. (Pubitemid 27465551)
28. Petitti DB. Meta-analysis, decision analysis, and cost-eff ectiveness analysis. New York: Oxford University Press; 1994.
29. Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634. (Pubitemid 27387172)
30. Niu W, Qi Y. An updated meta-analysis of endothelial nitric oxide synthase gene: three well-characterized polymorphisms with hypertension. PLoS ONE 6(9): e24266.
31. Ueda K, Cardarelli C, Gottesman MM, et al. Expression of a full-length cDNA for the human " MDR1 " gene confers resistance to colchicine, doxorubicin, and vinblastine. Proc Natl Acad Sci USA 1987;84:3004-3008.
32. Tanigawara Y. Role of P-glycoprotein in drug disposition. Ther Drug Monit 2000;22:137-140. (Pubitemid 30083115)
33. Terao T, Hisanaga E, Sai Y, et al. Active secretion of drugs from the small intestinal epithelium in rats by P-glycoprotein functioning as an absorption barrier. J Pharm Pharmacol 1996;48:1083-1089. (Pubitemid 26400301)
34. Th iebaut F, Tsuruo T, Hamada H, et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc Natl Acad Sci USA 1987;84:7735-7738.
35. Chaudhary PM, Roninson IB. Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells. Cell 1991;66:85-94. (Pubitemid 121001349)
36. Elliott JI, Raguz S, Higgins CF. Multidrug transporter activity in lymphocytes. Br J Pharmacol 2004;143:899-907. (Pubitemid 39664849)
37. Hitzl M, Drescher S, Van Der Kuip H, et al. The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+natural killer cells. Pharmacogenetics 2001;11:293-298. (Pubitemid 32537402)
38. Chong AS, Markham PN, Gebel HM, et al. Diverse multidrugresistance- modifi cation agents inhibit cytolytic activity of natural killer cells. Cancer Immunol Immunother 1993;36:133-139. (Pubitemid 23026419)
39. Gupta S, Kim CH, Tsuruo T, et al. Preferential expression and activity of multidrug resistance gene 1 product (P-glycoprotein), a functionally active efflux pump, in human CD8+T cells:a role in cytotoxic effector function. J Clin Immunol 1992;12:451-458.
40. Drach J, Gsur A, Hamilton G, et al. Involvement of P-glycoprotein in the transmembrane transport of interleukin-2 (IL-2), IL-4, and interferon-gamma in normal human T lymphocytes. Blood 1996;88:1747-1754. (Pubitemid 26307071)
41. Pawlik A, Baskiewicz-Masiuk M, Machalinski B, et al. Involvement of C3435T and G2677T multidrug resistance gene polymorphism in release of cytokines from peripheral blood mononuclear cells treated with methotrexate and dexamethasone. Eur J Pharmacol 2005;528: 27-36. (Pubitemid 41773648)
42. Song P, Lamba JK, Zhang L, et al. G2677T and C3435T genotype and haplotype are associated with hepatic ABCB1 (MDR1) expression. J Clin Pharmacol 2006;46:373-379. (Pubitemid 43260324)
43. Kimchi-Sarfaty C, Oh JM, Kim IW, et al. A " silent " polymorphism in the MDR1 gene changes substrate specifi city. Science 2007;315: 525-528. (Pubitemid 46175758)
44. Brinkmann U, Roots L, Eichelbaum M. Pharmacogenetics of the human drug-transporter gene MDR1: impact of polymorphisms on pharmacotherapy. Drug Discov Today 2001;6:835-839. (Pubitemid 32734511)
45. Nauck M, Stein U, Karger SV, et al. Rapid detection of the C3435T polymorphism of multidrug resistance gene 1 using fl uorogenic hybridization probes. Clin Chem 2000;46:1995-1997.
46. Kim RB, Leake BF, Choo EF, et al. Identifi cation of functionally variant MDR1 allele among European Americans and African Americans. Clin Pharmacol Ther 2001;70:189-199. (Pubitemid 32777772)
47. Wang D, Johnson AD, Papp AC, et al. Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C+T aff ects mRNA stability. Pharmacogenet Genomics 2005;15:693-704. (Pubitemid 41345321)
48. Shen LX, Basilion JP, Stanton VP Jr. Single-nucleotide polymorphisms can cause diff erent structural folds of mRNA. Proc Natl Acad Sci USA 1999;96:7871-7876. (Pubitemid 29328374)